Election Committee Disqualifies MK Ofer Cassif and Sami Abu Shehadeh
The Central Elections Committee has disqualified Member of Knesset Ofer Cassif and Balad party chairman Sami Abu Shehadeh from running in the upcoming Knesset elections. The decision to disqualify Cassif, a member of the Joint List, was made by a vote of 19 to 5, based on a petition by the Likud party alleging he denies the existence of Israel as a Jewish and democratic state. Likud's attorney accused Cassif of supporting convicted terrorists and using terms like "genocide." Cassif's defense argued his statements were protected by freedom of speech.
Abu Shehadeh was disqualified by a significantly larger margin, 31 to 4, on grounds of supporting armed struggle or a terror organization against Israel. In a rare move, the committee's chairman, Justice Noam Sohlberg, broke with tradition and voted in favor of Abu Shehadeh's disqualification, stating the case was clear-cut. Abu Shehadeh had referred to the October 7th Hamas attack as a "historically significant event" in an article, though he later expressed regret and denied advocating violence.
The committee's decisions are subject to appeal at the Supreme Court, which will have the final say. The disqualification of Cassif was opposed by the Attorney General's representative, who argued his statements, while harsh, did not meet the legal threshold for supporting a terror organization. However, parties like Yisrael Beiteinu and Yair Golan's The Democrats supported the disqualifications.
The heated debate within the committee highlighted deep divisions over the boundaries of Israeli democracy and the eligibility of controversial candidates. Numerous petitions for disqualification have been filed recently, targeting candidates from across the political spectrum.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.